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PURPOSE. We aimed to establish an efficient method for retinal ganglion cell (RGC)
differentiation from human pluripotent stem cells (hPSCs) using defined factors.
METHODS. To define the contribution of specific signal pathways to RGC development and
optimize the differentiation of hPSCs toward RGCs, we examined RGC differentiation in three
stages: (1) eye field progenitors expressing the eye field transcription factors (EFTFs), (2) RGC
progenitors expressing MATH5, and (3) RGCs expressing BRN3B and ISLET1. By monitoring
the condition that elicited the highest yield of cells expressing stage-specific markers, we
determined the optimal concentrations and combinations of signaling pathways required for
efficient generation of RGCs from hPSCs.
RESULTS. Precise modulation of signaling pathways, including Wnt, insulin growth factor-1,
and fibroblast growth factor, in combination with mechanical isolation of neural rosette cell
clusters significantly enriched RX and PAX6 double-positive eye field progenitors from hPSCs
by day 12. Furthermore, Notch signal inhibition facilitated differentiation into MATH5-positive
progenitors at 90% efficiency by day 20, and these cells further differentiated to BRN3B and
ISLET1 double-positive RGCs at 45% efficiency by day 40. RGCs differentiated via this method
were functional as exemplified by their ability to generate action potentials, express
microfilament components on neuronal processes, and exhibit axonal transportation of
mitochondria.
CONCLUSIONS. This protocol offers highly defined culture conditions for RGC differentiation
from hPSCs and in vitro disease model and cell source for transplantation for diseases related
to RGCs.
Keywords: human pluripotent stem cells, induced pluripotent stem cells, retinal ganglion
cells, defined factors, differentiation
Retinal ganglion cells (RGCs) transmit the visual informationprocessed by retinal cells, such as photoreceptors and
bipolar cells, to the lateral geniculate body through the optic
nerve, optic tract, optic chiasm, and optic radiation.1 These
cells are affected by several pathological conditions, including
optic neuropathies and glaucoma.2 Particularly, glaucoma,
which is characterized by progressive death of RGCs, is the
leading cause of irreversible blindness and more than 70 million
people suffer from glaucoma worldwide.3,4 Although medica-
tions and surgery for glaucoma are available, 10% of glaucoma
patients still lose their vision despite receiving appropriate
treatment.5 The loss of RGCs has been also implicated in
genetic optic neuropathy, such as Leber’s hereditary optic
neuropathy and dominant optic atrophy.6 Both optic neurop-
athies show bilateral and aggressive loss of vision in younger
patients, and no promising treatment has been developed for
these conditions.
Recent advances in stem cell biology have indicated that
stem cells can be used as an alternative therapy for such
incurable RGC-related diseases.7 Particularly, human pluripo-
tent stem cells (hPSCs) derived from patients with genetic
defects are an excellent in vitro model for studying the
pathophysiology of these diseases and developing new drugs.
To develop treatment strategies employing stem cell technol-
ogy, an efficient differentiation method for RGCs is required.
Several methods for generating RGCs from hPSCs (embryonic
stem cells [ESCs] and induced pluripotent stem cells [iPSCs])
have been reported, and one group has applied their method
for modeling an RGC disease with inherent genetic alter-
ations.8–13
Differentiation methods for retinal cells often involve three-
dimensional (3D) culture of PSCs to allow for self-organization of
the primordial structure of the eye.14,15 These structures include
optic vesicles and optic cups, which eventually give rise to most
retinal lineages, including photoreceptors, retinal pigmented
epithelia (RPE), and RGCs within the structure. Under such
culture conditions, various retinal cell types arise and are
arranged in a proper retinal layer; however, the large-scale
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culture or enrichment of particular retinal cells (i.e., RGCs) may
be limited. Other studies have employed an adherent culture
platform either from the beginning or following 3D culture;
however, because of the heterogeneity of the cell population
and low yield of RGCs in culture, an enrichment step was still
required.9,12 Insufficient specification of a specific retinal cell
type may result from using methods that rely on the inherent
differentiation program of an individual hPSC line. Induction of
retinal cells based on such methods is not always efficient for
certain hPSC lines, particularly when some display an unfavor-
able propensity toward retinal fate.16 Other studies attempted
to specify RGCs by modulating the cellular signals involved in
RGC development during neural differentiation from
hPSCs.10,13,17 This approach resulted in substantial technical
advances; however, modulation of cellular signals occurs in a
less-defined manner via treatment with a cocktail of chemicals,
signaling molecules, and sometimes fetal bovine serum, thus
resulting in a low yield of RGCs. Additionally, this unclearly
defined cocktail makes it difficult to determine which signaling
pathway and the extent of pathway modulation are required to
maximize RGC differentiation.
To define the contribution of specific signal pathways to
RGC development and thereby to optimize the differentiation
of hPSCs toward RGCs, we dissected the process of RGC
differentiation into three stages as in vivo: (1) eye field
progenitors expressing a set of transcription factors (eye field
transcription factors [EFTFs]), (2) RGC progenitors expressing
MATH5, and (3) RGCs expressing BRN3B and ISLET1.18–24 In
each stage, the roles of several key signaling pathways in RGC
differentiation were investigated using different concentrations
and combinations of small molecules and peptide modulators.
While monitoring the condition showing the highest yield of
cells expressing stage-specific markers, we identified the
signaling pathways that require modulation and level of
modulation required for efficient generation of RGCs from
hPSCs.
METHODS
Culture of hPSCs and Differentiation of RGCs
Human ESCs (H9 [WA09, P35–50], WiCell, Madison, WI, USA)
and human iPSCs derived from healthy subjects25 were
cultured on mitotically arrested mouse fibroblasts (STO, CRL-
1503, American Type Culture Collection, Manassas, VA, USA)
in human ESC medium composed of DMEM/F12 medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 20%
Knockout-Serum Replacement (Invitrogen), 13 nonessential
amino acids (Invitrogen), 0.1 mM beta-mercaptoethanol
(Sigma-Aldrich Corp., St. Louis, MO, USA), and 4 ng/mL basic
fibroblast growth factor (bFGF, Peprotech, Rocky Hill, NJ,
USA). To induce eye field progenitors, embryoid bodies (EBs)
were cultured for 4 days in suspension with 5 lM dorsomor-
phin (DM; Calbiochem, La Jolla, CA, USA), 5 lM SB431542 (SB;
Sigma-Aldrich Corp.), 0.5 to 1 lM XAV939 (XAV; Calbiochem),
and 5 to 10 ng/mL insulin-like growth factor-1 (IGF-1;
Peprotech) in human ESC medium without bFGF. After
transferring the cells to Matrigel (BD Biosciences, San Jose,
CA, USA)-coated dishes, EBs were cultured in N2 medium
containing DMEM/F12 and 13 N2 (Gemini Bio-Products, West
Sacramento, CA, USA) supplemented with 2 lL/mL insulin
(Sigma-Aldrich Corp.), 1 lM XAV, and 10 to 60 ng/mL bFGF for
an additional 4 days. Neural rosettes that appeared in the
center of attached EB colonies were carefully isolated from the
surrounding flat cells using pulled glass pipettes, and then
small rosette clumps were seeded onto Matrigel-coated dishes
after gentle trituration. These cells were then cultured in
N2B27 medium containing DMEM/F12, 13 N2, and 13 B27
without vitamin A (Invitrogen) supplemented with 20 ng/mL
bFGF. Upon reaching approximately 90% confluence, the cells
were dissociated into single cells by incubation with Accutase
(Millipore, Billerica, MA, USA) and re-plated onto new Matrigel-
coated dishes in N2B27 medium. The culture medium was
changed every day, and cells were passaged every 2 to 3 days
for further expansion. For differentiation toward RGCs, cells
were seeded onto poly-D-lysine (Sigma-Aldrich Corp.) and
laminin (BD Biosciences)-coated dishes and cultured in N2B27
medium supplemented with 4 lM with N-(N-[3,5-difluorophe-
nacetyl]-L-alanyl)-S-phenylglycine t-butyl ester (DAPT; Sigma-
Aldrich Corp.) for 10 days. Brain-derived neurotrophic factor
(BDNF; Peprotech) was added beginning on day 16 to improve
the survival of neurons by the end of differentiation. A
schematic process for RGC differentiation is shown in
Supplementary Figure S1.
Quantitative Polymerase Chain Reaction
Total RNA was isolated using the Easy-Spin Total RNA
Extraction Kit (iNtRON Biotechnology, Gyeonggi-Do, Korea),
and cDNA was then synthesized from 1 lg total RNA using the
PrimeScript RT Master Mix (Takara Bio, Shiga, Japan).
Transcript levels were quantified by real-time RT-PCR assays
using SYBR Premix Ex Taq (Takara Bio) and the CFX96 Real-
Time System (Bio-Rad, Hercules, CA, USA). Ct values for each
targeted gene were normalized according to b-actin expres-
sion, and the normalized expression levels of the targeted
genes were compared to control samples using the compar-
ative Ct method. Data are expressed as the mean relative
expression 6 standard error of the mean (SEM) from at least
three independent experiments. Primers sequences are pro-
vided in Supplementary Table S1.
Immunocytochemistry Analysis
Cells fixed in 4% paraformaldehyde phosphate-buffered saline
(PBS) were permeabilized with 0.1% Triton X-100-PBS solution
for 10 minutes and then blocked with 2% bovine serum
albumin in PBS for 1 hour at room temperature. Next, the cells
were incubated with primary antibodies overnight at 48C. The
following primary antibodies were used in our study: SOX2,
1:200, Millipore [MAB4343]; PLZF, 1:50, Calbiochem [OP129L];
RX, 1:300, Abcam (Cambridge, UK) [ab23340]; PAX6, 1:100,
DSHB (Iowa City, IA, USA) [pax6]; LHX2, 1:300, Santa Cruz
Biotechnology (Dallas, TX, USA) [sc-19344]; MATH5, 1:500,
Millipore [AB5694]; BRN3B, 1:200, Santa Cruz Biotechnology
[sc-31989]; ISLET1, 1:200, Abcam [ab20670]; TUJ1, 1:1000,
BioLegend (San Diego, CA, USA) [801201]; and NF-L, 1:200,
Millipore [AB9568].
Appropriate fluorescence-tagged secondary antibodies (Mo-
lecular Probes, Eugene, OR, USA) were used for visualization.
Cells were mounted in DAPI mounting medium (Vector
Laboratories, Burlingame, CA, USA) and images were obtained
using an IX71 microscope equipped with a DP71 digital
camera (Olympus, Tokyo, Japan) or FSX100 all-in-one fluores-
cence microscope system (Olympus). Positively-labeled cells
were counted manually by blinded examiners or using an
image analysis program (MetaMorph version 7.17; Molecular
Devices, Sunnyvale, CA, USA) with at least six randomly
captured images from three independent experiments.
Time-Lapse Imaging for Axonal Transportation of
Mitochondria
RGCs at day 40 of differentiation were labeled with Mitotracker
Red CMXRos (Molecular Probes) according to the manufactur-
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er’s instructions and observed with an Eclipse Ti-U inverted
microscope equipped with a DS-U3 camera and Intensilight C-
HGFI (Nikon, Tokyo, Japan) under 4003 magnification. Live
imaging was performed for 30 seconds to 2 minutes at each
region of interest, and time-lapse images were acquired every 7
seconds from the recorded video clips.
Electrophysiological Analysis
Electrophysiological examinations were performed with human
ESC and iPSC-derived RGCs using the whole-cell patch clamp
technique as reported previously.26 Briefly, cultured cells were
transferred into a bath mounted on a stage with an inverted
microscope (IX-70, Olympus). Cells subjected to electrophysio-
logical recording were identified by the morphological features
of RGCs such as their medium-sized (15–25 lm in diameter) and
oval-shaped soma with two or more intensively long processes.27
The conventional whole-cell clamp was achieved by rupturing
the patch membrane after forming a gigaseal. The bath solution
(124 mM NaCl, 3 mM KCl, 1.25 mM KH2PO4, 2.5 mM MgSO4, 3.4
mM CaCl2, 26 mM NaHCO3, 10 mM glucose [pH 7.4]) was
perfused at 1.5 mL/min and continuously gassed with 95% O2
and 5% CO2. The standard pipette solution for the whole-cell
patch clamp contained 130 mM K-gluconate, 10 mM KCl, 8 mM
NaCl, 2 mM MgATP, 0.5 mM GTP, 10 mM HEPES, and 0.2 mM
ethylene glycol tetraacetic acid (pH 7.2). The voltage and current
recordings were performed at room temperature (228C–258C).
Patch pipettes with a free-tip resistance of approximately 2 to 5
MX were connected to the head stage of the patch-clamp
amplifier (Axopatch-700B, Molecular Devices). pCLAMP soft-
ware version 10.2 and Digidata-1440A (Molecular Devices) were
used to acquire data and apply command pulses. AgCl reference
electrodes were connected to the bath via a 1.5% agar bridge
containing 3 M KCl. Voltage and current traces were stored and
analyzed using Clampfit version 10.2 and Origin version 8.0
(OriginLab Corp., Northampton, MA, USA). Currents were
sampled at 5 kHz. All data were low-pass filtered at 1 kHz.
Depolarizing currents to induce action potentials were injected
at 0.01 mA for 500 ms. All data are presented as the mean6 SEM.
Statistical Analysis
Data are shown as the mean 6 SEM of at least three
independent replicates. Data were analyzed by two-tailed
Student’s t tests or analysis of variance when two or more
groups were involved. Statistical analyses were performed
using SPSS version 23 software (SPSS, Inc., Chicago, IL, USA).
RESULTS
To initiate retinal differentiation from human ESCs, we induced
the neuroectoderm by simultaneously inhibiting both bone
morphogenic protein (BMP) and transforming growth factor
beta (TGFb) signals using two small molecules, DM and SB, as
previously described.28 An attachment culture of EBs pre-
exposed to these small molecules for 4 days generated colonies
with neural rosette structures (Supplementary Figs. S2A–C).
Most cells in the structure were positive for SOX2 and PLZF,
which are markers of neural rosette cells (Supplementary Figs.
S2D, S2E), confirming robust neural induction. Thus, we utilized
this method as a basis for generating eye field progenitors.
Inhibition of Wnt in Combination With Activation
of IGF Induces Eye Field Progenitors
The eye field is first specified in the anterior neural plate as
the eye primordium, which eventually forms the visible optic
cup via evagination of the diencephalic wall.19 This region
can be identified by specific expression of EFTFs, such as
Pax6, Rx, Six3, and Lhx2.19 Previous studies showed that the
anterior fate of the neuroectoderm is greatly enhanced upon
inhibition of canonical Wnt signaling.29 Thus, we first tested
whether Wnt signal inhibition facilitates anteriorization of
the neuroectoderm as well as eye field specification. To this
end, we employed XAV, a potent tankyrase inhibitor, to
inhibit canonical Wnt signaling.30 We treated EBs with 1 lM
XAV for 4 days in the presence of small molecule inhibitors of
BMP and TGFb. Quantitative gene expression analysis of
neuroectoderm markers and the anteroposterior axis re-
vealed that XAV treatment significantly upregulated the
expression of a forebrain marker, BF1 (also known as
FOXG1), whereas such treatment downregulated expression
of mid- and hindbrain markers, EN1 and GBX2, compared to
levels in the DM and SB-treated control group (Fig. 1A). The
expression level of SOX1, a pan-neural marker gene, was not
significantly different in XAV-treated cells compared to in a
control (Fig. 1A). We next examined whether Wnt inhibition
promotes the expression of EFTFs. As shown in Figure 1B,
treatment of EB-stage cells with 0.5 to 1 lM XAV for 4 days
significantly enhanced the expression of EFTFs. XAV treat-
ment with 1.0 lM did not significantly increase PAX6
expression compared to the control condition (DM and SB
only), while 0.5 lM of XAV did increase PAX6 expression.
However, the fold-increase in PAX6 by XAV treatment was
marginal at both concentrations (1.56-fold at 0.5 lM and
1.13-fold at 1.0 lM), and upregulation of RX and SIX3 by XAV
treatment was robust at 1.0 lM and displayed a clear dosage-
dependency (4.11- and 3.67-fold at 0.5 lM and 18.46- and
12.95-fold at 1.0 lM). Therefore, we used 1.0 lM XAV for
retinal induction.
Based on a previous study that reported IGF-1 as a positive
regulator of eye and head induction in Xenopus,31 we
examined whether IGF-1 treatment enhances the expression
of anterior markers and/or EFTFs. When EBs were exposed to
IGF-1 in the presence of DM and SB for 4 days, BF1 and OTX2
(another anterior marker) were slightly but significantly
upregulated by 1.42- and 1.38-fold, respectively, while GBX2
was downregulated by 2.32-fold with no significant change in
EN1 expression compared to in DM- and SB-treated cells (Fig.
1C). The fold-change in anteroposterior marker expression
following IGF-1 treatment was not as robust as that following
XAV treatment; however, IGF-1 treatment significantly in-
creased the expression of all EFTFs tested (2.2- and 2.4-fold
for PAX6, 12.7- and 17.6-fold for RX, 2.3- and 2.1-fold for SIX3,
and 2.5- and 2.0-fold for LHX2 by 5 and 10 ng/mL of IGF-1,
respectively) and showed a clear dose-dependent effect on RX
(Fig. 1D). Thus, our results indicate that IGF-1 treatment
imparts eye field identity to differentiating neural progenitors
and induces anteriorization.
Because both IGF-1 and XAV treatment promoted anterio-
rization and eye field fate, we tested whether co-treatment of
these cells with IGF-1 and XAV would have an additive effect
on eye field specification. Addition of 10 ng/mL IGF-1 in
combination with DM, SB, and 1 lM XAV to the EB culture
increased the expression of RX and SIX3 by 32.5- and 30.2-fold
compared to expression in EB cultures treated with DM and SB
only (Fig. 1E). These expression levels were 1.8- and 2.3-fold
greater than those in DM, SB, and XAV-treated EB cultures (Fig.
1B versus Fig. 1E). The expression of PAX6 was not
significantly increased, possibly because PAX6 expression in
EB cultures already peaked by co-treatment with DM and SB.32
Together, our data suggest that Wnt inhibition and IGF
activation cooperatively promote eye field fate during neural
induction of human ESCs.
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Enrichment of Eye Field Progenitors by Treatment
With bFGF and Mechanical Isolation of Rosette
Structure
To further investigate the effect of modulating additional
signaling pathway(s) on eye field specification, we transferred
EBs onto Matrigel-coated dishes after culture in the presence of
DM, SB, XAV, and IGF-1 for 4 days. Various stimuli, including
retinoic acid, acidic FGF, bFGF, and purine agonist were tested
in the adherent culture. None of the stimulants, such as the
purine agonist 2-methylthioadenosine diphosphate trisodium,
all-trans retinoic acid, and acidic FGF, significantly increased
the expression of RX and SIX3 when added to cultures for 4
days (data not shown). However, treatment with a high dose of
bFGF (60 ng/mL) upregulated the expression of both RX and
SIX3 by 4.6- and 3.9-fold, respectively, compared to nontreated
cells (Fig. 2A). In zebrafish, Fgf-8 regulates axial patterning of
the prospective neural retina,33 and Fgf-3 and Fgf-19 regulate
Hedgehog signaling, which is required for differentiation of the
vertebrate retina.34,35 Given that bFGF can bind to several FGF
receptors that bind the retina-inducing FGFs mentioned above
(i.e., FGFR3c, FGFR2c, and FGFR1b) with different affinities,36
it is possible that only high concentrations of bFGF are
effective for eye field specification.
Morphological identification has been employed to enrich
RGCs from a heterogeneous population.10 In adherent
cultures, the colonies of attached EBs were a heterogeneous
mixture of neural rosette cells and surrounding nonrosette-
FIGURE 1. Modulation of Wnt and IGF signals promoted anteriorization and eye field specification. (A) Wnt inhibition anteriorized the cells in
neural differentiation of human ESCs. (B) Wnt inhibition increased the expression of EFTFs, particularly RX and SIX3, in a dose-dependent manner.
(C) IGF-1 showed anteriorizing effect in neural induction of human ESCs. (D) IGF-1 significantly upregulated the expression of EFTFs. (E) Wnt
inhibition and IGF activation cooperatively increased the expression of RX and SIX3. All data are presented as the mean 6 SEM. Significant
differences are indicated as *P < 0.05.
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type cells, which could be distinguished morphologically
(Supplementary Figs. S2B, S2C). To determine whether the
two cell types differ in their potential for RGC differentiation,
we assessed EFTF gene expression following dissection of the
two cell types under a microscope. Relative gene expression
analysis clearly showed higher expression of EFTFs in the
rosette group than in the nonrosette group (Fig. 2B). Moreover,
neural rosette cells obtained from eye field-inducing conditions
were strongly labeled with antibodies against PAX6 and RX,
and approximately 60% of the total cells coexpressed PAX6 and
RX under these conditions, while only 6.7% coexpression was
observed under control conditions with DM and SB treatment
only (Figs. 2C–E). Considering that nonneural rosette cells that
appeared around the neural rosette clumps after neural
induction were mainly composed of neural crest cells37 and
that neural crest cells never follow the RGC lineage, it was not
surprising that isolation of neural rosette enriches eye-field
progenitors. The neural rosette cells at this stage were
cryopreservable and propagated without changing their
characteristics after thawing (data not shown). Given the high
proportion of cells with dual-immunoreactivity for PAX6 and
RX, we referred to cells at this stage as eye field progenitors
and used these cells for further RGC differentiation.
FIGURE 2. Treatment with bFGF and isolation of neural rosette enriched eye field progenitors. (A) Quantitative RT-PCR analysis showed that
treatment with a high concentration (60 ng/mL) of bFGF significantly upregulated RX and SIX3 compared to the untreated control group. (B)
Expression of EFTFs (PAX6, RX, SIX3, but not LHX2) was higher in neural rosette clusters than in nonneural rosette cells. (C–E) RX and PAX6-
double positive cells were more prevalent (up to 60% of total cells) in neural rosette clusters isolated from neural culture treated with DM, SB, XAV,
IGF-1, and bFGF than in neural cells induced by treatment with DM and SM. (C) and (D) show representative immunofluorescent images of each
group, and (E) shows the results of quantitative analysis of RX and PAX6 double-positive cells in the cultures. Scale bar: 100 lm. Data are presented
as the mean 6 SEM. Significant differences are indicated as *P < 0.05.
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Notch Signal Inhibition Induces RGCs From Eye
Field Progenitors via MATH5-Positive RGC
Progenitor Stage
Cell cycle exit can be induced by Notch signal inhibition.38
Additionally, Notch activity is downregulated just prior to
RGC differentiation in intact developing chick retinas39 and
Notch signaling appears to control the stage-dependent
phenotypic potential of retinal progenitors.40 Because RGCs
are first generated from retinal progenitors by mitotic exit
during retina development,41 we predicted that RGCs would
accumulate following early Notch signal inhibition. To test
this hypothesis, we treated the eye field progenitors with
DAPT, a small molecular inhibitor of Notch signaling.
Morphological examination revealed that oval-shaped cell
bodies with extended bipolar dendrites were prominent 1
week after DAPT treatment (Fig. 3A), indicating facilitation of
neuronal differentiation. Immunocytochemical analysis for
the RGC precursor marker MATH5 (also known as ATOH7)
and pan-neuronal marker TUJ1 revealed that up to 90% 6 2%
of total cells were double-positive for these markers 8 days
after beginning DAPT treatment (at day 20; Fig. 3B). Because
of the high percentage of MATH5-positive cells observed, we
referred to this cell stage as MATH5-positive RGC progeni-
tors.
For terminal maturation, the MATH5-positive RGC progen-
itors were further cultured in differentiation medium supple-
mented with BDNF for 3 to 4 weeks. At day 26 of
differentiation, quantitative gene expression analysis showed
that MATH5-positive RGC progenitors cultured under matura-
tion conditions expressed significantly higher levels of RGC
markers, including BRN3B, and the cell-surface glycoprotein
THY142 than neural cells differentiated under non-RGC-
inducing conditions (Figs. 3C, 3D). At day 40 of differentiation,
numerous cells formed small cell clusters, intensively network-
ing with each other via long neuronal processes (Fig. 3E).
Immunocytochemistry with antibodies against BRN3B and
ISLET1 followed by quantitative analysis revealed that 51.8% 6
7.9% of cells were BRN3B-positive, 74.7% 6 5.5% of cells were
ISLET1-positive, and 44.6% 6 7.3% of cells were positive for
both markers (Fig. 3F).
We then examined the time-course of expression of the
following markers representative of retinal lineages: RPE
marker MITF,43 photoreceptor marker CRX,44 amacrine cell
marker BARHL2,45 horizontal cell marker PROX1,46 Mu¨ller
cell marker GLUL,47 retinal progenitor and bipolar cell marker
CHX10 (also known as VSX-2),48 and RGC markers BRN3B
and c-synuclein (SNCG).49 The relative expression of markers
in cells cultured under RGC-inducing conditions normalized
to expression in cells grown under control conditions
revealed robust upregulation of all EFTFs (SIX3, RX, and
LHX2) in the early stage (days 4–8), followed by delayed
upregulation of the retinal progenitor marker CHX10 at day
12 (Fig. 3G). Markers for RGCs (MATH5, BRN3B, and SNCG)
were highly upregulated at later stages of differentiation (at
days 19–40), suggesting that RGC differentiation proceeded
via a normal developmental trajectory as observed for RGCs
in developing retinas.19 Interestingly, only transient upregu-
lation of MITF and PROX1 expression was observed at day 12
and 19, respectively, and upregulation of BARHL2 was
particularly high at day 19 (Fig. 3G). No significant change
in the expression of CRX was observed, indicating that the
differentiation of photoreceptors was negligible. These
results demonstrate that other retinal lineage cells (e.g.,
RPE, horizontal cells, and amacrine cells) arise together with
RGCs under the conditions used in this study. Nonetheless,
the high proportion of BRN3B and ISLET1 double-positive
cells and timely upregulation of various RGC makers
reminiscent of in vivo RGC development suggest that our
differentiation strategy involving defined modulation of
cellular signals is efficient for inducing RGCs from human
ESCs.
Functionality of RGCs Derived From hPSCs
To determine whether the human ESC-derived RGCs were
functionally active, we examined their electrophysiological
properties at day 40 of differentiation. In all recordings, the
subject cells were carefully selected based on the morpho-
logical features of RGCs27 (Fig. 4A) as described in the
Methods section, although such an approach is often
accompanied by a risk of off-targeting. In voltage-clamp
mode, most neurons examined showed fast inward sodium
currents and an outward rectifying potassium current (Fig.
4B). In current-clamp mode, the resting membrane potential
was 30.4 6 1.9 mV and amplitude of the first action
potential was 37.7 6 2.7 mV in human ESC-derived neurons
(n ¼ 12) (Supplementary Table S2). Human ESC-derived
neurons (70.6%, n ¼ 12/17) consistently produced trains of
action potentials in response to the depolarizing current
injection under the current-clamp mode (Fig. 4C). We also
observed spontaneous firings for a few neurons (Fig. 4D),
indicating that neurons prepared using our system were
electrophysiologically active.
The extensive projection of neuronal processes also
prompted us to examine whether RGCs express neurofilament
(NF) proteins using immunocytochemistry (Figs. 4E–F).
Immunoreactivity of the NF component, neurofilament-light
(NF-L), was strong on neuronal processes emanating from the
cell cluster with BRN3B-immunoreactivity (Fig. 4E). Cells in
less dense areas clearly exhibited dual immunoreactivity for
NF-L and BRN3B and bipolar morphology (Fig. 4F). Given the
role of NF in action potential transmission,50 intensive
expression of an NF component further supports the
functionality of the differentiated cells as RGCs.
Strong expression of an NF component on its axons led
us to examine whether the RGCs were capable of axonal
transportation of mitochondria, which is one of the
functional characteristics of RGCs. As shown in Figure 4G
and the Supplementary Video, time-lapse imaging analysis
using Mitotracker as a tracer of mitochondria clearly
revealed mitochondrial transport along a neuronal axon.
Even within a relatively short time frame (30 seconds–2
minutes), numerous clusters of mitochondria were trans-
ported bi-directionally with frequent pausing. Taken togeth-
er, our data strongly suggest that the RGCs differentiated
under our defined culture conditions were functionally
active.
Finally, we tested the robustness of our method by
generating RGCs from human iPSCs. Differentiation of human
iPSCs by our RGC protocol produced RX and PAX6 double-
positive cells at comparable efficiency in the eye field
progenitor stage (day 12; Fig. 5A), and more than 90% of cells
were positive for MATH5 and TUJ1 at day 20 (Fig. 5B). Further
neuronal maturation following DAPT treatment generated
terminally differentiated RGCs expressing BRN3B, ISLET1,
and TUJ1 (Figs. 5C, 5D). Human iPSC-derived RGCs showed
electrophysiological properties comparable to those of human
ESC-derived RGCs (Figs. 5E–G, Supplementary Table S2). Most
(80%, n ¼ 16/20) consistently produced trains of action
potentials in response to depolarizing current injection under
the current-clamp mode (Fig. 5G), and a few neurons
spontaneously fired action potentials (Fig. 5H), indicating that
iPSC-derived neurons prepared using our system were
electrophysiologically active.
Generation of Human Retinal Ganglion Cells IOVS j July 2018 j Vol. 59 j No. 8 j 3536
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937362/ on 11/12/2018
DISCUSSION
Our study presents a rapid, yet highly efficient, differentiation
paradigm for generating RCGs from hPSCs. Fine modulation of
the Wnt, IGF, and FGF signaling pathways, along with
mechanical isolation of neural rosette clusters, generated an
enriched cell population highly committed to retinal fate.
Precocious cell cycle exit driven by Notch inhibition facilitated
FIGURE 3. Notch inhibition facilitated differentiation of RGCs from eye field progenitors. (A) Representative bright-field image of RGC progenitors
differentiating under Notch inhibition. (B) Immunofluorescent image showing that most differentiating cells coexpressed MATH5 and TUJ1. (C, D)
Quantitative RT-PCR analysis at day 26 of differentiation showing significant upregulation of RGC markers ([C] for BRN3B and [D] for THY1) under
RGC-induction conditions. (E) Representative image of 40-day-old neurons differentiating under RGC-inducing conditions. (F) Coexpression of
BRN3B and ISLET1 in 40-day-old neurons differentiating under RGC-inducing conditions. (G) Time-course expression of retinal markers during RGC
differentiation. Bars in the graph represent the relative expression of each marker in cells differentiating under RGC-inducing conditions normalized
to those cultured under control conditions without RGC-inducing factors (XAV, IGF-1, and bFGF). Scale bar: 100 lm. Data are presented as the mean
6 SEM. Significant differences indicated as *P < 0.05.
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differentiation of these cells toward functional RGCs. As a
result, we obtained MATH5-positive cells at more than 90%
efficiency by day 20. Subsequent neuronal maturation gener-
ated BRN3B and ISLET1 double-positive RGCs at approximately
45% efficiency by day 40, which is the highest yield of BRN3B
and ISLET1 double-positive cells reported from hPSCs without
using cell sorting (Table). Most importantly, the differentiated
RGCs exhibited characteristics of functional RGCs, including
FIGURE 4. Functional assessment of differentiated RGCs from human ESCs. (A) Representative image of glass electrodes approaching neurons for
patch-clamp recording. (B) Representative current traces (upper panels) recorded in voltage-clamp mode. Cells were depolarized by voltage steps
from80 toþ100 mV in 10-mV increments (lower panels). (C) Voltage responses evoked by current steps (10 toþ35 pA in 5-pA increments, lower
panel). (D) Spontaneous action potentials recorded in human ESC-derived RGCs. The arrow indicates membrane potentials. (E–F)
Immunofluorescent images of neuronal cells coexpressing BRN3B and NF-L. The arrow in panel (F) indicates an RGC with co-immunoreactivity
for BRN3B and NF-L. (G) Time-lapse images of Mitotracker-labeled neurons. Images were acquired under 4003magnification. Arrowheads follow
the movement of a mitochondria cluster labeled by the tracer. Scale bar: 100 lm.
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generation of action potentials, expression of microfilament
components, and axonal transportation of mitochondria.
The eye field firstly appears in the medial anterior neural
plate of the human embryo at Carnegie stage 10 (4 weeks after
gestation),18 in which EFTFs are highly expressed, constituting
a regulatory network for eye development.19 This region forms
the optic vesicle, then optic cup, and eventually undergoes
retinal differentiation for following 2 weeks or more. RGCs are
the first being born in developing neural retina.20 Math5 is
known to be required for commitment to RGCs and optic
nerve formation, and its expression is primarily detected in
embryonic day 11.5 mouse embryos (approximately equivalent
to 5 weeks after gestation in human).21,22 The Math5 gene is
also known to function upstream of Brn3s to promote RGC
development,23 which occurs at embryonic days 11.5 to 12.5
in mice (approximately at 5–5.5 weeks in human), and Brn3
expression continues until embryonic day 15.5 (8 weeks in
human), when most RGCs are generated.24
Our differentiation method generates eye-field progenitors
from human ESCs in 8 days. Because ES cells are derived from
the blastocyst, a 5- to 6-day-old embryo,51 our method only
required 2 weeks to differentiate the eye-field progenitors,
which is 2 weeks earlier than expected in the normal
developmental process. The efficient conditions used for
neural induction by treatment with DM and SB in conjunction
with promoting anteriorization (inhibition of WNT signal) and
proretinal signaling (IGF-1) appeared to have increased the rate
of retinal development. Thereafter, differentiation of MATH5-
positive progenitors and BRN3-positive neurons from eye-field
progenitors was facilitated by Notch signal inhibition, as the
respective cells defined by the markers dominated the
population earlier than in the developmental time course.
Despite our optimization efforts, the fates of more than half
of the differentiated cells remained unclear. Considering the
highly enriched eye field progenitor and RGC progenitor
populations, the unidentified cells were likely retinal progen-
FIGURE 5. Generation of RGCs from human iPSCs. (A) Immunofluorescent image of human iPSC-derived neural cells coexpressing RX and PAX6 at
the eye field progenitor stage. (B) Human iPSCs were differentiated to MATH5 and TUJ1 double-positive cells on day 20 at a comparable efficiency to
human ESCs. (C, D) After neuronal maturation (at day 40), human iPSC-derived neurons clustered intensively extending neuronal processes to each
other and showed strong immunoreactivity of BRN3B (C) and ISLET1 (D). (E) Representative current traces recorded in voltage-clamp mode. (F)
Trains of action potentials evoked by current steps (10 toþ35 pA in 5-pA increments, lower panel). (G) Spontaneous action potentials recorded in
human iPSC-derived RGCs. The arrow indicates membrane potentials. Scale bars: 100 lm.
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itors still undergoing the maturation process or other retinal
cells, such as horizontal cells and amacrine cells, as exempli-
fied by their time-course gene expression (Fig. 3G). To further
enhance the differentiation efficiency toward RGCs, modula-
tion of other signals may be effective. For example, RA
signaling plays an important role in retinal development.52
RARa and RXRc are expressed in the ganglion cell layer in the
developing mouse retina,53 and RA treatment for several days
induces axonal growth in optic vesicles differentiated from
human PSCs.9 Although our early treatment with RA did not
efficiently promote eye field specification, RA treatment in a
later stage may be beneficial for maturation or axonal
outgrowth of RGCs. The organic acid taurine (2-aminoethane-
sulfonic acid) may be another option because it is the most
abundant molecule in the retina and has been implicated in the
neuroprotection of RGCs.54 Additionally, modulation of the
TGFb pathway may enhance the yield of differentiated RGCs
because GDF11, a member of the TGFb superfamily, is known
to control the number of RGCs in the developing retina by
controlling the proliferation of retinal progenitors expressing
MATH5.55 More recently, treatment with an adenylate cyclase
activator was shown to promote eye field fate and RGC
commitment in human ESCs.12 Thus, additional fine modula-
tion of such signals at the appropriate cellular stage may
further improve the efficiency of RGC differentiation.
Although the heterogeneity issue requires further investi-
gation, our study provides highly defined culture conditions for
RGC differentiation, and these conditions can be manipulated
to further increase efficiency and homogeneity. Given the
applicability to human iPSCs, our method has remarkable
potential for future applications, such as cell therapy, drug
screening, and disease modeling for RGC-related diseases,
including glaucoma and mitochondrial optic neuropathies.
TABLE. Comparison Between Our Method and Recently Published Protocols for Differentiation of RGCs From hPSCs
Cell Type
Modulated
Signals
RGC
Marker Yield
Functional
Assays
Time
Required Similarity Difference
Reference
Number
hPSC Dorsomorphin and
SB431542 (dual
SMAD inhibitors),
XAV939 (Wnt
inhibitor),
IGF-1, bFGF, DAPT
(Notch inhibitor)
BRN3B, ISL1,
NF-L
~45% Action
potentials,
Cytoskeleton
in axons,
Axonal
transport
40 d – – The present
method
hPSC DAPT (Notch
inhibitor)
BRN3A, ISL1,
SNCG, THY1
~22% Action
potentials,
Excitatory
postsynaptic
currents
40 d Notch inhibitor
for early cell
cycle exit
3D culture 8
hiPSC IWR-1e (Wnt
inhibitor),
CHIR99021 (Wnt
agonist),
SAG (Shh agonist)
BRN3B, ISL1,
SNCG, TAU,
NF-L/M/H
N/A Action
potentials,
Cytoskeleton
in axons,
Axonal
transport
34 d Wnt inhibition for
eye-field
3D culture
followed by
adherent
culture
9
hPSC N/A BRN3, ISL1,
HUC/D,
RBPMS, TAU
~36% Action
potentials,
Cytoskeleton
in axons
50 d None 3D culture 10
hESC Forskolin (Enhance
cell survival)
BRN3B, BRN3A,
THY1, RBPMS,
PAX6, ISL1,
NEUN, NF-H,
TAU
~10% Action
potentials,
Cytoskeleton
in axons
40 d None Differentiation
was carried out
using only one
condition
11
hESC Noggin (BMP4
inhibitor), Dkk-1
(Wnt inhibitor),
IGF-1, bFGF
THY1.1, BRN3A,
HUC/D, NF-M
~77% Action
potentials,
Cytoskeleton
in axons,
Axonal
transport
45 d Eye-field
progenitors by
Wnt inhibitor
Cell sorting
mediated by
THY1.1
13
hiPSC Noggin, Dkk-1, IGF-
1,Shh, FGF8,
DAPT,
Cyclopamine (Shh
inhibitor)
BDNF, NT4, CNTF,
Forskolin, Y27632
(enhance cell
survival)
BRN3/THY1 ~26% Action
potentials,
In vivo
explant
culture
36 d Wnt inhibition for
eye-field/Notch
inhibitor for
early cell cycle
exit
Usage of Shh
signal
modulators
17
DKK-1, Dickkopf-related protein 1; CNTF, ciliary neurotrophic factor; NT4, neurotrophin4; Shh, Sonic Hedgehog.
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SUPPLEMENTARY MATERIAL
SUPPLEMENTARY VIDEO. Live images of Mitotracker-labeled
neurons. Live images using Mitotracker as a tracer of
mitochondria demonstrated mitochondrial transport along a
neuronal axon. Numerous clusters of mitochondria were
transported bi-directionally with frequent pausing. Images
were acquired under 4003 magnification.
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